Krishna Institute of Medical Sciences Limited

Krishna Institute of Medical Sciences Limited

669.60
INR
-4.05
(-0.60%)
4.85EPS
161.03P/E
344.99BMarket Cap
Nov 06Next Earn
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
2026 Y
TTM
Revenue per Share
22.94
28.06
35.05
41.56
54.17
61.83
75.06
96.77
105.18
Basic EPS, GAAP
-1.19
2.98
5.37
8.38
8.41
7.75
9.61
6.03
5.1
Free Cash Flow per Basic Share
1.41
3.74
6.99
3.87
-3.56
-3.15
-10.67
-22.92
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
13.51
14.95
21.59
34.67
41.72
45.69
53.43
56.17
- -
Tangible Book Value per Share
10.97
12.17
18.85
31.76
32.08
36.38
43.27
46.28
- -
Basic Weighted Avg Shares
400
400
374
397
400
400
400
400
401
Sales/Revenue/Turnover
9,180
11,226
13,122
16,508
21,677
24,740
30,035
38,721
42,125
Operating Margin (%)
13.1
16.1
23.48
26.84
22.22
20.26
20.5
13.83
11.92
Depreciation Expense
565
706
695
727
1,293
1,465
1,772
2,832
3,306
Net Income, GAAP
-478
1,192
2,012
3,327
3,363
3,100
3,845
2,414
2,043
Effective Tax Rate (%)
- -
18.11
26.36
24.75
24.56
26.9
25.68
27.52
29.77
Profit Margin (%)
-5.2
10.62
15.33
20.15
15.52
12.53
12.8
6.23
4.85
Working Capital
-270
10
1,729
1,784
1,812
954
-1,389
-3,015
- -
LT Debt
2,882
3,143
2,279
2,263
6,336
12,265
22,873
36,374
- -
Total Equity
5,669
6,114
8,762
14,106
19,380
20,931
24,188
25,585
- -
Return on Invested Capital (%)
- -
16.07
21.44
23.93
17.93
12.33
11.21
6.55
- -
Return on Capital (%)
- -
16.46
20.12
23.33
15.36
10.49
9.97
6.5
- -
Return on Common Equity (%)
- -
20.93
27.53
29.56
22
17.73
19.39
11.01
- -

Capital Structure

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
ST Debt
- -
6,155
- -
LT Borrowings
- -
26,726
- -
LT Finance Leases
- -
9,648
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
400
400
420
Market Capitalization
242,924
249,106
344,993

Working Capital

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
Total Current Assets
- -
9,374
- -
Cash, Cash Equivalents & STI
- -
705
- -
Accounts Receivable, Net
- -
5,542
- -
Inventories
- -
969
- -
Total Current Liabilities
- -
12,389
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
6,155
- -
Deferred Revenue
- -
- -
- -

Growth Rates

INR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
25.55%
5.78%
Free Cash Flow
- -
21.61%
114.73%
Net Income, GAAP
- -
9.08%
-37.22%
Sales/Revenue/Turnover
- -
24.31%
28.92%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
6,884
7,773
7,724
7,969
30,035
2026
8,716
9,607
9,977
10,746
38,721
2027
11,795
- -
- -
- -
- -

Quarterly Earnings Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
2.16
2.68
2.22
2.54
9.61
2026
1.96
1.67
1.33
1.06
6.03
2027
1.04
- -
- -
- -
- -

Quarterly Dividends Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
2027
- -
- -
- -
- -
- -

Company Description

CEO
Bollineni Abhinay
Full Time Employees
18,491
Sector
Health services
Industry
Hospital/Nursing management
Address
D. No. 1-8-31/1 Secunderabad TS India 500003
IPO Date
Jun 28, 2021
Business
Krishna Institute of Medical Sciences Limited (KIMS Hospitals) operates a chain of multi-specialty hospitals providing integrated tertiary and quaternary healthcare services across more than 25 specialties, including cardiac sciences, oncology, neurosciences, gastroenterology, orthopaedics, organ transplantation, renal sciences, mother and child care, neurology, neurosurgery, pulmonology, rheumatology, robotics, urology, critical care, emergency and trauma services, interventional cardiology and oncology, and advanced diagnostics such as MRI, CT scans, and laboratory medicine; the company maintains NABH and NABL accreditations and is listed on the National Stock Exchange of India. Founded in 2000 by Dr. Bhaskar Rao Bollineni with its first hospital in Nellore, Andhra Pradesh, KIMS Hospitals is headquartered in Secunderabad, Telangana, and serves patients primarily in tier-2 and tier-3 cities across Telangana, Andhra Pradesh, Maharashtra, Kerala, Karnataka, with a network exceeding 8,300 beds including its flagship 1,000-bed facility in Secunderabad. Recent expansions include new hospitals in Nashik (Maharashtra, 2024), Kannur (Kerala, 2024), Guntur (Andhra Pradesh, 2025), Sangli (Maharashtra, 2025 via partnership with UAIMS Hospital including a call option for majority stake), Kollam (Kerala, 2025), Thane (Maharashtra, 2025), and Bangalore (Karnataka, 2025 with a 450-bed multi-specialty facility); acquisitions such as Chalasani Hospitals in Visakhapatnam (2024 for Rs 28 crore), Kingsway Hospital in Nagpur (2022), and others like AsianTranscare and MIPPL in Hyderabad (2024); launches of advanced services including AI-based early warning systems (2025), paediatric cardiac surgery, ECMO, liver transplants, cancer centres, and expansions adding over 1,500 beds in locations like Bengaluru, Ongole, Anantapur, Kondapur, and Rajahmundry.